Document Type : Case Report
Authors
Department of General Medicine, Government Medical College and Hospital, Sector 32, Chandigarh, India
Abstract
Objective: Lithium is a principal drug used in the treatment of bipolar disorder (BPD). Due to its narrow therapeutic index, serum levels need to be monitored regularly. In elderly patients with renal dysfunction lithium toxicity can develop paradoxically within the therapeutic range. This can lead to erroneous diagnosis and delayed treatment resulting in irreversible neurological sequelae as is described in our case.
Case Presentation: A 65-year-old hypertensive female, with a 7-year history of BPD presented with decreased oral intake since 5-7 days, followed by altered sensorium. Neurological examination revealed coarse tremors in bilateral upper and lower limbs with spasticity, hyperreflexia, bilateral knee clonus. Twenty-five days earlier, she was prescribed Lithium carbonate. On evaluation she was found to have chronic kidney disease. Serum lithium levels came out to be 1.18 mg/dL (borderline high). After ruling out other differentials, a diagnosis of lithium toxicity was considered and she underwent two sessions of hemodialysis (HD) leading to significant improvement in sensorium; however, the patient had persistent dysarthria, difficulty in walking and proximal myopathy predominantly in the lower limbs. Nerve conduction studies confirmed the presence of axonal neuropathy. These findings of peripheral neuropathy (both sensory and motor) were suggestive of SILENT (syndrome of irreversible lithium-effectuated neurotoxicity).
Conclusion: Unintended lithium toxicity can occur even at therapeutic levels especially in the elderlies owing to its narrow therapeutic window, complex pharmacokinetics and numerous drug interactions. Lithium can result in irreversible neurotoxicity including SILENT; therefore, a high level of suspicion is required to prevent such permanent disability.
Keywords
Main Subjects
evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009; 11 Suppl 2: 92-109. doi: 10.1111/j.1399-5618.2009.00714.x.
2. Arancibia A, Corvalan F, Mella F, Concha L. Absorption and disposition kinetics of lithium carbonate following
administration of conventional and controlled release formulations. Int J Clin Pharmacol Ther Toxicol 1986;24(5): 240-5.
3. Cameron P, Little M, Mitra B, Deasy C. Textbook of Adult Emergency Medicine. 5th ed. Edinburgh: Churchill Livingstone; 2000. p. 753-5.
4. Ivkovic A, Stern TA. Lithium-induced neurotoxicity: clinical presentations, pathophysiology, and treatment.
Psychosomatics 2014; 55(3): 296-302. doi: 10.1016/j.psym.2013.11.007.
5. Haussmann R, Bauer M, von Bonin S, Grof P, Lewitzka U. Treatment of lithium intoxication: facing the need for
evidence. Int J Bipolar Disord 2015; 3(1): 23. doi: 10.1186/s40345-015-0040-2.
6. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium poisoning. J Intensive Care Med
2017; 32(4): 249-63. doi: 10.1177/0885066616651582.
7. Mégarbane B, Hanak AS, Chevillard L. Lithium-related neurotoxicity despite serum concentrations in the
therapeutic range: risk factors and diagnosis. Shanghai Arch Psychiatry 2014; 26(4): 243-4. doi: 10.3969/j.issn.1002-
0829.2014.04.009.
8. Foulser P, Abbasi Y, Mathilakath A, Nilforooshan R. Do not treat the numbers: lithium toxicity. BMJ Case Rep 2017;
2017. doi: 10.1136/bcr-2017-220079.
9. Peng J. Case report on lithium intoxication with normal lithium levels. Shanghai Arch Psychiatry 2014; 26(2): 103-
4. doi: 10.3969/j.issn.1002-0829.2014.02.008.
10. Strayhorn JM Jr, Nash JL. Severe neurotoxicity despite “therapeutic” serum lithium levels. Dis Nerv Syst 1977;
38(2): 107-11.
11. Nguyen L. Lithium II: irreversible neurotoxicity after lithium intoxication. J Emerg Nurs 2008; 34(4): 378-9. doi:
10.1016/j.jen.2008.04.026.
12. Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin
Neuropharmacol 2005; 28(1): 38-49. doi: 10.1097/01.wnf.0000150871.52253.b7.
13. Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984; 70(6): 594-602.
doi: 10.1111/j.1600-0447.1984.tb01254.x.
14. Decker BS, Goldfarb DS, Dargan PI, Friesen M, Gosselin S, Hoffman RS, et al. Extracorporeal treatment for lithium
poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol 2015;
10(5): 875-87. doi: 10.2215/cjn.10021014.
15. Ristic DI, Siapera MS, Jovic J, Marjanovic VS, Radovanovic M, Fountoulakis KN. Unrecognized acute lithium toxicity: a case report. Cent Eur J Med 2012; 7(6): 700-3. doi: 10.2478/s11536-012-0058-0.
16. Olfson M. Surveillance of adverse psychiatric medication events. JAMA 2015; 313(12): 1256-7. doi: 10.1001/
jama.2014.1574
)